Clinical Availability of Endoscopic Incision and Submucosal Dissection for the Treatment of Gastric Neoplasms.
10.5230/jkgca.2006.6.2.76
- Author:
Yoon Ho JUNG
1
;
Soo Hoon EUN
;
Joo Young CHO
;
In Seop JUNG
;
Chang Beom RYU
;
Joon Seong LEE
;
Moon Sung LEE
;
Chan Sup SHIM
;
Boo Sung KIM
Author Information
1. Department of Internal Medicine, Institute for Digestive Research, Soon Chun Hyang University College of Medicine, Seoul, Korea. schidr@hosp.sch.ac.kr
- Publication Type:Original Article
- Keywords:
Early gastric cancer;
Endoscopic treatment
- MeSH:
Adenoma;
Follow-Up Studies;
Hemorrhage;
Humans;
Recurrence;
Stomach Neoplasms*
- From:Journal of the Korean Gastric Cancer Association
2006;6(2):76-83
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Endoscopic incision and submucosal dissection (EISD) is a technique that is being implemented for the resection of gastric adenomas and early gastric cancer (EGC). Since EISD requires a high degree of skill and experience, and due to its association with a moderate risk of gastrointestinal bleeding, its use has been limited. The objective of this study is to investigate the clinical benefits of EISD based upon clinical data on the EISD procedure. MATERIALS AND METHODS: This study was conducted at Soonchunhyang University Hospital and it included 179 gastric adenoma and early gastric carcinoma lesions from 164 patients who had undergone an EISD from February 2003 to May 2005. RESULTS: Among the total of 179 lesions, the distributions of EGC and adenomas were 70.3% (126/179) and 23.4% (42/179) respectively. The sizes of lesions were divided into 10 mm or less, 11~20 mm, 21~30 mm and greater than 31 mm and each rates are 10.0% (18/179), 46.3% (83/179), 30% (50/179) and 15.6% (28/ 179). Among 120 cases which could be measured depth of lesion in according to pathologic findings, m1 (0.8%, 1/120), m2 (38.3%, 46/120), m3 (25%, 57/120), sm1 (11.7%, 14/120), sm2 (1.6%, 2/120) were diagnosed as early stages of gastric cancer. The complete resection rate was 85.2% (150/176) and en-bloc resection rate was 96.0% (169/176). Complications as such as perforation and bleeding developed in 4.4%(8/179) and 21.2% (38/ 179), respectively. CONCLUSION: EISD is an effective in the endoscopic treatment for gastric adenoma and early gastric cancers. However, further evaluation of this method and long-term follow-up will be necessary for an evaluation of the recurrence rate after resection of a tumor.
